Ocrelizumab

Denosumab is a human anti-RANKL mAb; Prolia for osteoporosis and Xgeva for bone metastases. Its semiannual subcutaneous dosing offers superior compliance vs oral bisphosphonates, with dual-market positioning across orthopedics and oncology.

Durvalumab is an anti-PD-L1 mAb and the standard PACIFIC consolidation therapy for unresectable Stage III NSCLC post-chemoradiation. As the sole immunotherapy for limited-stage SCLC, its precise positioning in radiation-immunotherapy combinations sets the benchmark for locally advanced tumor care.

Faricimab is the world's first bispecific antibody for ophthalmology, targeting both Ang-2 and VEGF-A. Enabling q16w dosing in DME/wAMD, it delivers a revolutionary compliance breakthrough and represents the next-generation blockbuster in retina.

Ipratropium Bromide and Salbutamol is a combination of ipratropium bromide (anticholinergic) and albuterol sulfate (beta2-adrenergic agonist) delivered via the soft mist inhaler. It provides superior relief of bronchospasm compared to either agent alone in COPD patients with persistent symptoms despite reg...

Leuprorelin uses lyophilized microsphere technology with leuprolide acetate embedded in biodegradable PLGA polymer microcapsules. The active drug is released in two phases—diffusion and bioerosion—enabling 3-month or 6-month dosing intervals. As a GnRH agonist, it induces pituitary desensitization to reduc...

Nusinersen is a modified antisense oligonucleotide (ASO) administered intrathecally. It binds to the ISS-N1 sequence in intron 7 of SMN2 pre-mRNA, promoting exon 7 inclusion and production of full-length functional SMN protein. Approved across all SMA phenotypes including Type I, II, III, and presymptomati...

Octreotide Scetate is a long-acting release formulation of octreotide acetate encapsulated in biodegradable PLGA microspheres, providing sustained release for approximately 28 days following intramuscular injection. It dramatically improves patient adherence and quality of life compared to multiple daily s...

Ofatumumab is an anti-CD20 mAb; it is used for CLL and relapsing multiple sclerosis. Its monthly subcutaneous self-injection enables thorough B-cell depletion with significantly superior compliance vs intravenous CD20 alternatives.

Paclitaxel is a Cremophor-free, albumin-bound paclitaxel formulation where paclitaxel is delivered in a suspension of albumin nanoparticles. It is administered as a 30-minute IV infusion without steroid or antihistamine premedication. It eliminates the need for Cremophor EL solvent, thereby removing the ri...

Paliperidone Palmitate is a long-acting injectable (LAI) formulation using nanocrystal technology. It is supplied as prefilled syringes requiring no refrigeration or reconstitution, offering once-monthly (1M) and three-monthly (3M) dosing options for schizophrenia, which significantly improves treatment ad...

Panitumumab is a fully human anti-EGFR mAb for RAS wild-type metastatic colorectal cancer. Its fully human sequence minimizes immunogenicity, with proven survival benefit in FOLFOX combination, representing a key precision therapy option in CRC.

Pegfilgrastim is a PEGylated long-acting G-CSF for chemotherapy-induced neutropenia prophylaxis. Its extended half-life reduces dosing from daily to once per chemotherapy cycle, minimizing treatment delays and serving as the benchmark in oncology supportive care.

Q

Up to now, 

d

Up to now, there are a

There are